These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7264873)

  • 1. Saframycin S, a new saframycin group antibiotic.
    Mikami Y; Yokoyama K; Tabeta H; Nakagaki K; Arai T
    J Pharmacobiodyn; 1981 Apr; 4(4):282-6. PubMed ID: 7264873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C.
    Arai T; Takahashi K; Ishiguro K; Mikami Y
    Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discovery and development of unknown potentialities of microorganisms with special reference to saframycin group antitumor antibiotics].
    Arai T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2617-24. PubMed ID: 6508318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of new semisynthetic saframycin derivatives.
    Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T
    Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of saframycins.
    Kishi K; Yazawa K; Takahashi K; Mikami Y; Arai T
    J Antibiot (Tokyo); 1984 Aug; 37(8):847-52. PubMed ID: 6480503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DC-52, a novel antitumor antibiotic. 1. Taxonomy, fermentation and biological activity.
    Tomita F; Takahashi K; Shimizu K
    J Antibiot (Tokyo); 1983 May; 36(5):463-7. PubMed ID: 6860429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor activity of macromomycin].
    Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and biological activity of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone analogs. 1. Substitution at the S atom].
    Schulze W; Gutsche W; Wohlrabe K; Fleck W; Tresselt D
    Pharmazie; 1985 Aug; 40(8):540-1. PubMed ID: 4080797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of safracins A and B, heterocyclic quinone antibiotics, on experimental tumors in mice.
    Okumoto T; Kawana M; Nakamura I; Ikeda Y; Isagai K
    J Antibiot (Tokyo); 1985 Jun; 38(6):767-71. PubMed ID: 4019320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Griseorubins, a new family of antibiotics with antimicrobial and antitumor activity. II. Biological properties and antitumor activity of the antibiotic complex griseorubin.
    Dornberger K; Berger U; Gutsche W; Jungstand W; Wohlrabe K; Härtl A; Knöll H
    J Antibiot (Tokyo); 1980 Jan; 33(1):9-12. PubMed ID: 7372557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porothramycin, a new antibiotic of the anthramycin group: production, isolation, structure and biological activity.
    Tsunakawa M; Kamei H; Konishi M; Miyaki T; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1988 Oct; 41(10):1366-73. PubMed ID: 3192492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium.
    Irschik H; Trowitzsch-Kienast W; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1988 Aug; 41(8):993-8. PubMed ID: 2459096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrazomine, a new antibiotic produced by an actinomycete strain. Taxonomy, fermentation, isolation and characterization.
    Suzuki K; Sato T; Morioka M; Nagai K; Abe K; Yamaguchi H; Saito T; Ohmi Y; Susaki K
    J Antibiot (Tokyo); 1991 May; 44(5):479-85. PubMed ID: 2061191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro.
    Nagumo A; Takanashi K; Hojo H; Suzuki Y
    Toxicol Lett; 1991 Nov; 58(3):309-13. PubMed ID: 1957326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vermiculin derivatives. Part 1: Synthesis of vermiculin derivatives.
    Proksa B; Uhrín D; Adamacová J; Múcková M; Fuska J
    Pharmazie; 1993 Oct; 48(10):738-40. PubMed ID: 8265708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological properties of new benz[h]isoquinoline derivatives.
    Janin YL; Carrez D; Riou JF; Bisagni E
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):892-5. PubMed ID: 8020124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and conformation of saframycin R determined by high field 1H and 13C NMR and its interactions with DNA in solution.
    Lown JW; Hanstock CC; Joshua AV; Arai T; Takahashi K
    J Antibiot (Tokyo); 1983 Sep; 36(9):1184-94. PubMed ID: 6630077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased production of saframycin A and isolation of saframycin S.
    Arai T; Takahashi K; Ishiguro K; Yazawa K
    J Antibiot (Tokyo); 1980 Sep; 33(9):951-60. PubMed ID: 7440416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.